What laboratory tests should be ordered to evaluate for cancer in a patient with weight loss, fatigue, and abdominal problems?

Laboratory Workup for Cancer in Patients with Weight Loss, Fatigue, and Abdominal Problems

Order a comprehensive initial panel including CBC with differential, comprehensive metabolic panel (including liver function tests, serum calcium, LDH, albumin), inflammatory markers (ESR and CRP), and urinalysis, followed by targeted tumor markers based on age, sex, and clinical presentation 1, 2, 3.

Initial Basic Laboratory Tests (Order for All Patients)

The foundational workup should include:

• Complete blood count (CBC) with differential - evaluates for anemia, thrombocytosis, and leukocytosis, all associated with occult malignancy 4, 5, 6, 3
• Comprehensive metabolic panel including:
  • Serum calcium (corrected) - elevated in multiple cancers 4
  • Liver function tests (ALT, AST, alkaline phosphatase, GGT) - critical for hepatobiliary malignancies 5, 3
  • Serum albumin - low levels strongly associated with cancer (positive likelihood ratio 3.24) 7, 3
  • Lactate dehydrogenase (LDH) - elevated in various malignancies 4, 5
  • Renal function (creatinine, BUN) 4, 5
• Inflammatory markers:
  • C-reactive protein (CRP) - elevated CRP has positive likelihood ratio of 3.13 for cancer 7
  • Erythrocyte sedimentation rate (ESR) 8, 3
• Urinalysis 4, 5, 8

Critical finding from recent research: Abnormal results including low albumin, raised platelets (positive likelihood ratio 3.48), elevated total white cell count (positive likelihood ratio 3.01), and elevated CRP are strongly predictive of cancer in patients with unexplained weight loss 7. However, normal blood tests do not rule out cancer 7.

Age and Sex-Specific Tumor Markers

For Men ≥40 Years:

• Prostate-specific antigen (PSA) - mandatory for all men over 40 with adenocarcinoma or carcinoma not otherwise specified, except those with metastases limited to liver or brain 1, 2

For Men with Mediastinal or Retroperitoneal Findings:

• β-human chorionic gonadotropin (β-hCG) 1, 2
• α-fetoprotein (AFP) 1, 2
• Consider testicular ultrasound if these markers are elevated 1

For Women with Abdominal/Pelvic Symptoms:

• CA-125 - especially for mediastinal, peritoneal, or retroperitoneal malignancies 1, 9, 2
• CA 15-3 - if breast primary suspected 2

For Gastrointestinal Symptoms:

• Carcinoembryonic antigen (CEA) 2, 10
• CA 19-9 2, 10
• CA 72-4 2
• AFP - for hepatocellular carcinoma when liver involvement present (upgraded to category 2A recommendation) 1

Additional Markers Based on Clinical Suspicion:

• Chromogranin A - if neuroendocrine tumor suspected 2
• Ferritin - particularly relevant with weight loss 11, 8
• Serum protein electrophoresis - especially with back pain (used in 18% of cancer patients presenting with back pain) 11

Important Clinical Context

The diagnostic yield is substantial: In a study of 276 patients with isolated involuntary weight loss, 38% had cancer, predominantly of the digestive system (54%) 3. The median survival was only 2 months, emphasizing the urgency of prompt evaluation 3.

Positive predictive value considerations: Men ≥50 years and women ≥60 years with unexplained weight loss have >3% cancer risk, warranting urgent investigation even without additional features 7. In younger patients, concurrent clinical features significantly increase cancer risk 7.

Panel performance: When one or more tumor markers are positive, the positive predictive value is 0.55, and when combined with suspicious CT findings, this increases to 0.92 10. A completely negative tumor marker panel has a negative predictive value of 0.84, increasing to 0.96 in the absence of suspicious CT findings 10.

Common Pitfalls to Avoid

• Do not rely on normal blood tests to exclude cancer - only 2 patients with cancer in one study had completely normal initial laboratory tests 3
• Do not order tumor markers indiscriminately - target based on clinical presentation and imaging findings 2, 10
• Do not forget thyroid function (TSH) - hypothyroidism can mimic cancer-related fatigue and weight loss 6, 8
• Do not overlook medication review - polypharmacy can cause weight loss and fatigue independent of malignancy 12, 8

Algorithmic Approach

1. First tier (order immediately): CBC, CMP (including calcium, LDH, albumin, liver enzymes), CRP/ESR, urinalysis
2. Second tier (based on initial results and demographics):
   • Men ≥40: Add PSA
   • Abdominal symptoms: Add CEA, CA 19-9, AFP
   • Women with pelvic/abdominal findings: Add CA-125
   • Mediastinal/retroperitoneal mass in younger patients: Add β-hCG, AFP
3. Third tier (based on imaging and clinical suspicion): Additional organ-specific markers as indicated

The routine laboratory tests combined with abdominal imaging detect the majority of cancers in patients with isolated involuntary weight loss 3, making this a cost-effective and clinically appropriate initial strategy.